Literature DB >> 24178971

Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals.

Xiaoxi Zeng1, Gearoid M McMahon, Steven M Brunelli, David W Bates, Sushrut S Waikar.   

Abstract

BACKGROUND AND OBJECTIVES: At least four definitions of AKI have recently been proposed. This study sought to characterize the epidemiology of AKI according to the most recent consensus definition proposed by the Kidney Disease Improving Global Outcomes (KDIGO) Work Group, and to compare it with three other definitions. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a retrospective cohort study of 31,970 hospitalizations at an academic medical center in 2010. AKI was defined and staged according to KDIGO criteria, the Acute Dialysis Quality Initiative's RIFLE criteria, the Acute Kidney Injury Network (AKIN) criteria, and a definition based on a model of creatinine kinetics (CK). Outcomes of interest were incidence, in-hospital mortality, length of stay, costs, readmission rates, and posthospitalization disposition.
RESULTS: AKI incidence was highest according to the KDIGO definition (18.3%) followed by the AKIN (16.6%), RIFLE (16.1%), and CK (7.0%) definitions. AKI incidence appeared markedly higher in those with low baseline serum creatinine according to the KDIGO, AKIN, and RIFLE definitions, in which AKI may be defined by a 50% increase over baseline. AKI according to all definitions was associated with a significantly higher risk of death and higher resource utilization. The adjusted odds ratios for in-hospital mortality in those with AKI were highest with the CK definition (5.2; 95% confidence interval [95% CI], 4.1 to 6.6), followed by the RIFLE (2.9; 95% CI, 2.2 to 3.6), KDIGO (2.8; 95% CI, 2.2 to 3.6), and AKIN (2.6; 95% CI, 2.0 to 3.3) definitions. Concordance in diagnosis and staging was high among the KDIGO, AKIN, and RIFLE definitions.
CONCLUSIONS: The incidence of AKI in hospitalized individuals varies depending on the definition used. AKI according to all definitions is associated with higher in-hospital mortality and resource utilization. AKI may be inappropriately diagnosed in those with low baseline serum creatinine using definitions that incorporate percentage increases over baseline.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24178971      PMCID: PMC3878695          DOI: 10.2215/CJN.02730313

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  36 in total

1.  Validity of information on comorbidity derived rom ICD-9-CCM administrative data.

Authors:  Hude Quan; Gerry A Parsons; William A Ghali
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

2.  Comment on "RIFLE classification in patients with acute kidney injury in need of renal replacement therapy" by Maccariello et al.

Authors:  Rinaldo Bellomo; John A Kellum; Claudio Ronco
Journal:  Intensive Care Med       Date:  2007-07-20       Impact factor: 17.440

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

Review 4.  Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

Authors:  Matthew James; Josée Bouchard; Julie Ho; Scott Klarenbach; Jean-Phillipe LaFrance; Claudio Rigatto; Ron Wald; Michael Zappitelli; Neesh Pannu
Journal:  Am J Kidney Dis       Date:  2013-03-19       Impact factor: 8.860

5.  Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.

Authors:  Sushrut S Waikar; Ron Wald; Glenn M Chertow; Gary C Curhan; Wolfgang C Winkelmayer; Orfeas Liangos; Marie-Anne Sosa; Bertrand L Jaber
Journal:  J Am Soc Nephrol       Date:  2006-04-26       Impact factor: 10.121

6.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Authors:  Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates
Journal:  J Am Soc Nephrol       Date:  2005-09-21       Impact factor: 10.121

7.  An assessment of the RIFLE criteria for acute renal failure in hospitalized patients.

Authors:  Shigehiko Uchino; Rinaldo Bellomo; Donna Goldsmith; Samantha Bates; Claudio Ronco
Journal:  Crit Care Med       Date:  2006-07       Impact factor: 7.598

8.  Costs of adverse events in intensive care units.

Authors:  Rainu Kaushal; David W Bates; Calvin Franz; Jane R Soukup; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2007-11       Impact factor: 7.598

9.  Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

Authors:  Margaret C Fang; Yuchiao Chang; Elaine M Hylek; Jonathan Rosand; Steven M Greenberg; Alan S Go; Daniel E Singer
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  143 in total

Review 1.  Diagnostic Criteria for Acute Kidney Injury: Present and Future.

Authors:  John A Kellum
Journal:  Crit Care Clin       Date:  2015-08-05       Impact factor: 3.598

Review 2.  Acute kidney injury after transcatheter aortic valve implantation.

Authors:  Maximilian Scherner; Thorsten Wahlers
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

3.  Evaluation of acute kidney injury (AKI) with RIFLE, AKIN, CK, and KDIGO in critically ill trauma patients.

Authors:  F Ülger; M Pehlivanlar Küçük; A O Küçük; N K İlkaya; N Murat; B Bilgiç; H Abanoz
Journal:  Eur J Trauma Emerg Surg       Date:  2017-07-17       Impact factor: 3.693

4.  Intensity of Renal Replacement Therapy and Duration of Mechanical Ventilation: Secondary Analysis of the Acute Renal Failure Trial Network Study.

Authors:  Shilpa Sharma; Yvelynne P Kelly; Paul M Palevsky; Sushrut S Waikar
Journal:  Chest       Date:  2020-05-26       Impact factor: 9.410

5.  The Incidence of Acute Kidney Injury and Associated Hospital Mortality.

Authors:  Dmytro Khadzhynov; Danilo Schmidt; Juliane Hardt; Geraldine Rauch; Peter Gocke; Kai-Uwe Eckardt; Kai M Schmidt-Ott
Journal:  Dtsch Arztebl Int       Date:  2019-05-31       Impact factor: 5.594

6.  AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions.

Authors:  Scott M Sutherland; John J Byrnes; Manish Kothari; Christopher A Longhurst; Sanjeev Dutta; Pablo Garcia; Stuart L Goldstein
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

7.  Acute kidney injury in critically ill children and 5-year hypertension.

Authors:  Erin Hessey; Sylvie Perreault; Louise Roy; Marc Dorais; Susan Samuel; Véronique Phan; Jean-Philippe Lafrance; Michael Zappitelli
Journal:  Pediatr Nephrol       Date:  2020-03-11       Impact factor: 3.714

Review 8.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

Review 9.  Doppler ultrasound in kidney diseases: a key parameter in clinical long-term follow-up.

Authors:  Leonardo Spatola; Simeone Andrulli
Journal:  J Ultrasound       Date:  2016-04-16

10.  Cost-effectiveness of ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae bacteremia and pneumonia.

Authors:  Matthew S Simon; Maroun M Sfeir; David P Calfee; Michael J Satlin
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.